Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
8.94M
-
Shares change
-
+2.34M
-
Total reported value, excl. options
-
$33.2M
-
Value change
-
+$8.1M
-
Put/Call ratio
-
0
-
Number of buys
-
37
-
Number of sells
-
-23
-
Price
-
$3.71
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2018
81 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q2 2018.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.94M shares
of 79.8M outstanding shares and own 11.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.88M shares), ICONIQ Capital, LLC (1.71M shares), VANGUARD GROUP INC (1.48M shares), Tieton Capital Management, LLC (909K shares), STATE STREET CORP (531K shares), GEODE CAPITAL MANAGEMENT, LLC (295K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (268K shares), UBS Group AG (146K shares), NORTHERN TRUST CORP (119K shares), and WELLS FARGO & COMPANY/MN (118K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.